Equity Overview
Price & Market Data
Price: $1.10
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $45,193,172
Volume: 0
Performance Metrics
1 Week: 3.95%
1 Month: 2.80%
3 Months: -1.79%
6 Months: -29.03%
1 Year: -50.45%
YTD: -34.52%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.